VHL and von Hippel-Lindau disease: In our workflow, individuals positive for germline VHL variants who could benefit from somatic tumor evaluation fell in two categories: patients who had tumor(s) that were not component tumors of the VHL syndrome and patients who presented with only one VHL component tumor (Fig. 1).